The Treatment of Myasthenia Gravis

Most patients receiving treatment for myasthenia gravis will see disease improvement over time and may experience minimal symptoms or go into remission.

Pioneer HIV Capsid Inhibitor

Lenacapavir’s unique mechanism of action and resistance profile offer promise
for patients who have run out of antiretroviral treatment options.




The Management of Postoperative Pain

Multidisciplinary collaboration coupled with the use of multimodal strategies has enabled the tailoring of treatment plans based on the patient’s medical status and type of surgery.

Antithrombotic Therapy in Preventing Ischemic Stroke

Antiplatelet and anticoagulant agents are treatment mainstays, and pharmacists play a role in educating and monitoring at-risk patients on pharmacologic as well as nonpharmacologic interventions.

Pharmacists’ Vital Role in Identifying and Reporting Child Abuse

Awareness of how to recognize and report adverse childhood events helps break generational cycles of abuse, thereby protecting the most vulnerable members of society.

Trends in Heart Failure Prevalence, Treatment, and Burden

Heart failure affects approximately 6.7 million U.S. adults, up from 6 million in 2017. 

HEPLISAV-B

Take Quiz

Continuing Education

$7.95 Per CE Exam or $69 for 12 Lessons

Quick Poll

Does Your Pharmacy Have Enough COVID-19 Testing Supplies?